Diane M. Hargrove
Ferring Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Neuropeptides and Animal Physiology, Receptor Mechanisms and Signaling, Pancreatic function and diabetes, Estrogen and related hormone effects
Most-Cited Works
- → Isozyme-nonselective N-Substituted Bipiperidylcarboxamide Acetyl-CoA Carboxylase Inhibitors Reduce Tissue Malonyl-CoA Concentrations, Inhibit Fatty Acid Synthesis, and Increase Fatty Acid Oxidation in Cultured Cells and in Experimental Animals(2003)243 cited
- → Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TRβ subtype-selective thyromimetics(2003)94 cited
- → Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents(2010)91 cited
- → GLUT4 Overexpression in db/db Mice Dose-Dependently Ameliorates Diabetes But Is Not a Lifelong Cure(2001)76 cited
- → Discovery of Potent, Nonsteroidal, and Highly Selective Glucocorticoid Receptor Antagonists(2002)60 cited
- → Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome(2020)56 cited
- → Bioluminescent imaging in induced mouse models of endometriosis reveals differences in four model variations(2021)45 cited
- → An Arginine-Deficient Diet in Humans Does Not Evoke Hyperammonemia or Orotic Aciduria(1987)36 cited
- → Synthesis and Pharmacological Characterization of Novel Glucagon-like Peptide-2 (GLP-2) Analogues with Low Systemic Clearance(2016)36 cited
- → Glucose-dependent action of glucagon-like peptide-1(7-37) in vivo during short- or long-term administration(1995)35 cited